Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emmanuelle Tchernonog
University Hospital, Montpellier
Principal Investigator - Julien Depaus
UCL Namur
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinique Universite Catholique de Louvain Saint-Luc
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- University Hospital Gent
Ghent, Belgium
- Hopital Joliment
Haine-Saint-Paul, Belgium
- Az Groeninge
Kortrijk, Belgium
- Ucl Namur
Yvoir, Belgium
- Ch de Bourg En Bresse
Bourg-en-Bresse, France
- Chu Côte de Nacre
Caen, France
- Chu Henri Mondor
Créteil, France
- Chu de Dijon
Dijon, France
- Ch de Versailles - Hopital Andre Mignot
Le Chesnay, France
- Clinique Victor Hugo
Le Mans, France
- Chu de Limoges - Hopital Dupuytren
Limoges, France
- Chu Lyon Sud
Lyon, France
- Clinique de la Sauvegarde
Lyon, France
- Chu Montpellier
Montpellier, France
- Ch Region Mulhouse Et Sud Alsace
Mulhouse, France
- Hopital Necker Paris
Paris, France
- Chu de Bordeaux
Pessac, France
- Ch Annecy Genevois
Pringy, France
- Chu de Reims - Hopital Robert Debre
Reims, France
- Chu de Rennes - Pontchaillou
Rennes, France
- Ch de Roubaix-Hopital Victor Provo
Roubaix, France
- Iuct Oncopole de Toulouse
Toulouse, France
- Hôpital Bretonneau- Centre H. Kaplan
Tours, France
- Ch de Valenciennes
Valenciennes, France
- Chru de Nancy
Vandœuvre-lès-Nancy, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Jul 2017
- Primary completion
- 18 Oct 2019
- Completion
- 18 Oct 2019
- Last update posted
- 2 Sept 2020
- Registered enrollment
- 25
- Registry id
- NCT03225924
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.